NoIR 48% Orange SpectraShield Small 460-31
by NoIR
Last verified June 19, 2026 · classified June 8, 2026
What it is
Summary
AI-generated from vendor-published content · June 8, 2026
These are specialty tinted eyewear from NoIR, a company that has long produced filter lenses specifically for people with low vision conditions like macular degeneration, diabetic retinopathy, and photophobia. The orange-tinted lenses block all UV and blue light while transmitting about half the available light, which improves contrast and reduces glare — particularly useful for reading and tasks under fluorescent lighting. They fit over existing prescription glasses, which makes them practical for people who already wear corrective lenses. The 'Small' sizing (about 5 inches wide) is worth checking against your frame before ordering, as fit affects both comfort and how well the side shields block peripheral glare.
Quick Facts Catalog facts · auto-generated
- AT Act lending
- Out of pocket
- Vocational rehab
What Setup Looks Like
- Out of the box
Put on over or instead of existing glasses — no adjustment or pairing required.
Getting it
Try Before You Buy
Devices like this are often available to borrow through your state's AT Act program — typically free or low-cost — so you can try it before buying or pursuing funding.
Where to Get It
Some links may be affiliate links — WhatCanHelp may earn a small commission from purchases at no extra cost to you. More on affiliates →
How to Fund This
Equipment like this is often pursued through official state programs. These are common starting points — each program decides its own eligibility and what it covers, so the first step is always a phone call.
Compare & explore
Sources & fine print
Vendor facts (name, price, platforms, vendor link) sourced from NoIR — view on vendor site; last verified June 19, 2026.
Classification & description AI-generated from vendor-published content on June 8, 2026 · confidence: high. Vendor specs may lag; verify before relying on details in a clinical or funding artifact.